Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence

Hiddo J.L. Heerspink*, Johannes David Smeijer

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

13 Downloads (Pure)
Original languageEnglish
Pages (from-to)324
Number of pages1
JournalJournal of the American Society of Nephrology
Volume36
Issue number2
DOIs
Publication statusPublished - Feb-2025

Keywords

  • albuminuria
  • CKD
  • pharmacology
  • SGLT2

Cite this